[Table/Fig-3]:
Improvement seen with severity of lesions as parameter
| Improvement seen with severity of lesions as parameter | ||
|---|---|---|
| At 1st follow-up No.of cases (%) | At 2nd follow-up No.of cases (%) | |
| Oral Ivermectin single dose 200μg/kg body wt. | 32 (53.34%) | 16 (26.60%) |
| Topical Permethrin 5% cream single application | 43 (71.66%) | 10 (16.66%) |
| Topical GBHC 1% lotion single application | 28 (46.66%) | 15 (25.00%) |
| Topical BB 25% lotion single application | 29 (48.33%) | 10 (16.66%) |